Sign In

Clean Mobile charges its batteries with €7.7 million

6 April 2011 11:32
By Tornado Staff

Clean Mobile, a German developer of hybrid electric drives, has received €7.7 million from existing investors Earlybird Venture Capital, Capital-E, High-Tech Gründerfonds and SVTG Silicon Valley Technology Group and new investor iwis. The Series B round of financing secures Clean Mobile’s further development and expansion and will support the market entry of the company’s harmonic chain drive drive line designed for e-bikes and pedelecs.

Clean Mobile sells drive trains through vehicle manufacturers to commercial and private users. The company has developed technologies around the entire drive train, including efficiency battery management systems, optimized drives and integrated vehicle management systems. It raised its first round of €3.3 million in March 2008 and another round of €6.6 million in April 2010.

Related stories
VC funding abound for Dutch start-ups
Solar energy back on VCs' agenda?
Deal activity in Europe: London is back on top (after five years)
Interim score for 2014 deal activity: UK back in pole position
A Top VC’s Silicon Valley Update - Matthew Howard, NVP


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Oct 4€16.0MBiopharmaceuticals
Oct 1€12.5MWireless applications
Oct 1€3.1MBiotechnology
Oct 1€10.0MInternet services
Sep 30€25.0MSoftware development
Sep 29€7.1MComputer hardware
Sep 29€12.0MBiopharmaceuticals

For information on Europe's most extensive database on technology funding click here!


BIO-Europe 2015
November 2 - 4, 2015

November 10 - 11, 2015

Press Releases

Oct 6
versasec triples government security business

Sep 30
BioRegio STERN Management
tübingen-based start-up atriva therapeutics gmbh develops innovativ...

Sep 29
Magic Event
with 1.5 million euros in hand, is looking to attrac...

Sep 29
swarm64 as raises up to eur7.1m from alliance venture, target partn...

Sep 29
Cristal Therapeutics (formerly Cristal Delivery)
cristal therapeutics starts clinical phase i trial with nanomedicin...

About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.